OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - SANOFI Share Price

Certificat

DE000SH4RDM5

Market Closed - Boerse Frankfurt Warrants 11:38:56 07/06/2024 am IST
1.49 EUR -7.45% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - SANOFI
Current month-16.76%
1 month-18.13%
Date Price Change
07/24/07 1.49 -7.45%
06/24/06 1.61 +5.92%
05/24/05 1.52 -5.00%
04/24/04 1.6 -9.09%
03/24/03 1.76 -1.68%

Real-time Boerse Frankfurt Warrants

Last update June 07, 2024 at 11:38 am IST

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
WKN SH4RDM
ISINDE000SH4RDM5
Date issued 17/01/2022
Strike 106
Maturity Unlimited
Parity 10 : 1
Emission price 3.23
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.84
Lowest since issue 0.63

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.13 EUR
Average target price
108.2 EUR
Spread / Average Target
+18.72%
Consensus